Pharmaceutical

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation…

4 months ago

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation…

4 months ago

KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences…

4 months ago

KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences…

4 months ago

Infinx Invests in Maverick AI to Bring Real-Time Autonomous Medical Coding to Revenue Cycle Management

Strategic Partnership Combines Maverick's GenAI-Powered Autonomous Agents With Infinx's Deep RCM Expertise to Accelerate Coding Accuracy CUPERTINO, CALIFORNIA / ACCESS…

4 months ago

Infinx Invests in Maverick AI to Bring Real-Time Autonomous Medical Coding to Revenue Cycle Management

Strategic Partnership Combines Maverick's GenAI-Powered Autonomous Agents With Infinx's Deep RCM Expertise to Accelerate Coding Accuracy CUPERTINO, CALIFORNIA / ACCESS…

4 months ago

TridentCare Closes Acquisition of Shoreline Diagnostics, Solidifying Its California Presence With a Market-Leading Clinical Lab

SPARKS, MD / ACCESS Newswire / August 13, 2025 / TridentCare, the leading national provider of portable diagnostic services, has…

4 months ago

TridentCare Closes Acquisition of Shoreline Diagnostics, Solidifying Its California Presence With a Market-Leading Clinical Lab

SPARKS, MD / ACCESS Newswire / August 13, 2025 / TridentCare, the leading national provider of portable diagnostic services, has…

4 months ago

MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy

Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cellsĀ  CHICAGO , Aug. 13, 2025 (GLOBE NEWSWIRE)…

4 months ago

MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy

Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cellsĀ  CHICAGO , Aug. 13, 2025 (GLOBE NEWSWIRE)…

4 months ago